Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ras/Raf/ERK signalling and NF1.

Marie C Harrisingh¹, Alison C Lloyd

¹MRC Laboratory for Molecular Cell Biology and the Department of Biochemistry, University College London, Gower Street, London, UK.

Cell Cycle (Georgetown, Tex.)

|October 7, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NICE 2026 guideline for the diagnosis and management of kidney cancer.

The Lancet. Oncology·2026

Same author

Microenvironmental TGF-β is an early driver of NF1-associated tumor formation.

Cell reports·2026

Same author

Identification of CCL3 as a Schwann cell chemotactic factor essential for nerve regeneration.

Cell reports·2025

Same author

N-cadherin directs the collective Schwann cell migration required for nerve regeneration through Slit2/3-mediated contact inhibition of locomotion.

eLife·2024

Same author

Schwann Cells as Orchestrators of Nerve Repair: Implications for Tissue Regeneration and Pathologies.

Cold Spring Harbor perspectives in biology·2024

Same author

Retraction Notice to: Macrophage-Derived Slit3 Controls Cell Migration and Axon Pathfinding in the Peripheral Nerve Bridge.

Cell reports·2023

Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026

Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026

Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026

Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026

Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026

Same journal

MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.

Cell cycle (Georgetown, Tex.)·2026

See all related articles

Ras signalling drives Schwann cell de-differentiation, a key process in Neurofibromatosis Type 1 (NF1) tumor development. Understanding this mechanism is crucial for NF1 research.

Area of Science:

Cell Biology
Oncology
Neuroscience

Background:

Schwann cells are regenerative and can de-differentiate for repair.
Ras signalling is implicated in Schwann cell-derived tumors in Neurofibromatosis Type 1 (NF1).

Purpose of the Study:

To investigate the role of Ras/Raf/ERK signalling in Schwann cell de-differentiation.
To explore the contribution of this pathway to NF1 tumor formation.

Main Methods:

Review of existing literature on Ras signalling and Schwann cell biology.
Analysis of experimental findings linking Ras/Raf/ERK pathway to cell de-differentiation.

Main Results:

Ras/Raf/ERK signalling was found to drive the de-differentiation of myelinated Schwann cells.

Related Experiment Videos

This de-differentiation process is relevant to adult Schwann cell regeneration.

Conclusions:

Ras/Raf/ERK signalling plays a significant role in Schwann cell de-differentiation.
Findings offer insights into the mechanisms underlying tumor development in NF1 patients.